Clinical Trial Update: Vitamin K2 Intervention in Patients With Vitamin K Antagonists [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating vitamin K2 (menaquinone) intervention in patients on vitamin K antagonists has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• Menaquinone (Vitamin K2) (menaquinone)

Snippet

Sponsor: Danisco | Conditions: Thrombosis | Phase 2 | Status: COMPLETED